Hao Yan

7PUBLICATIONS
9CO-AUTHORS
Haematological tumoursSpeciation and extinctionCheminformatics and quantitative structure-activity relationshipsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 10, 2026
Liver-originated selective autophagy of BTD by alectinib underlies concurrent hepatotoxicity and dermatotoxicity.

|Mar 27, 2025
The inducible role of autophagy in cell death: emerging evidence and future perspectives.

Xiangliang Huang, Hao Yan, Zhifei Xu

|Jan 21, 2025
Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity.

Hao Yan, Xiangliang Huang, Yourong Zhou

|Jul 14, 2023
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL.

Hao Yan, Xiangliang Huang, Jiangxin Xu

|Jun 06, 2023
An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer.

Yourong Zhou, Yiming Yin, Jiangxin Xu

|May 13, 2023
Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis.

Hao Yan, Wentong Wu, Yuhuai Hu

Pageof 2

Frequent Collaborators

6 joint publications

Zhifei Xu

6 joint publications

Peihua Luo

5 joint publications

Bo Yang

5 joint publications

Qiaojun He